Preexisting Atrial Fibrillation as Predictor for Late-Time Mortality in Patients with End-Stage Renal Disease Undergoing Cardiac Surgery - A Multicenter Study

Abstract

Background: Although patients with end-stage renal disease (ESRD) are considered to be high-risk patients in cardiac surgery, the reported studies are rather small, resulting in unsatisfactory analyses of outcome determinants. Therefore, we aimed to identify possible risk factors, with a particular focus on the impact of pre-existing atrial fibrillation (AF) on the postoperative short-term and long-term mortality of ESRD patients undergoing cardiac surgery. Methods: In a multicenter study 522 patients with ESRD undergoing CABG only (62.9 %), valve surgery only (17.2 %), or both (19.9 %) with comparable demographic and other cardiac risk factor characteristics were investigated retrospectively over a period of 10 years. The outcome was divided into perioperative (within 30 days) and late morbidity and mortality, and multivariate analysis was performed for both. Results: The mean perioperative mortality was 11.5 % and the 5-year survival rate was 42 %. Emergency surgery, insulin-dependent diabetes mellitus, the number of vein grafts and age were identified as risk factors whereas complete revascularization, the use of an internal thoracic artery and the presence of sinus rhythm were identified as beneficial factors for long-term survival. 14.1 % of all patients had pre-existing AF. Although AF was not identified as an independent risk factor for perioperative mortality (p = 0.59), it was identified as an independent predictor for late mortality (p < 0.001). Median survival of patients without AF was 1816 days, while for patients with AF it was only 715 days. Conclusions: AF does represent an independent predictor for long-term but not perioperative mortality in patients with ESRD. However, effective treatment of AF is controversially discussed. Anticoagulation therapy or perioperative ablation of the arrhythmia should be considered in order to improve the survival of these patients.

Key words

cardiovascular surgery - coronary bypass surgery - heart valve surgery

References

• 1 Collins A J, Kasiske B, Herzog C. et al . Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.  Am J Kidney Dis. 2005;  45 (Suppl 1) A5-A7
• 2 Sarnak M J, Levey A S, Schoolwerth A C. et al . Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.  Circulation. 2003;  108 2154-2169
• 3 Szczech L A, Reddan D N, Owen W F. et al . Differential survival after coronary revascularization procedures among patients with renal insufficiency.  Kidney Int. 2001;  60 292-299
• 4 Herzog C A, Ma J Z, Collins A J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes.  Circulation. 2002;  106 2207-2211
• 5 Higgins T L, Estafanous F G, Loop F D. et al . Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score.  JAMA. 1992;  267 2344-2348
• 6 Horst M, Mehlhorn U, Hoerstrup S P, Suedkamp M, de Vivie E R. Cardiac surgery in patients with end-stage renal disease: 10-year experience.  Ann Thorac Surg. 2000;  69 96-101
• 7 Jault F, Rama A, Bonnet N. et al . Cardiac surgery in patients receiving long term hemodialysis. Short and long term results.  J Cardiovasc Surg (Torino). 2003;  44 725-730
• 8 Gelsomino S, Morocutti G, Masullo G. et al . Open heart surgery in patients with dialysis-dependent renal insufficiency.  J Card Surg. 2001;  16 400-407
• 9 Witczak B, Hartmann A, Svennevig J L. Multiple risk assessment of cardiovascular surgery in chronic renal failure patients.  Ann Thorac Surg. 2005;  79 1297-1302
• 10 Brinkman W T, Williams W H, Guyton R A, Jones E L, Craver J M. Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection.  Ann Thorac Surg. 2002;  74 37-42
• 11 Kaplon R J, Cosgrove 3rd D M. Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival.  Ann Thorac Surg. 2000;  70 438-441
• 12 Franga D L, Kratz J M, Crumbley A J. et al . Early and long-term results of coronary artery bypass grafting in dialysis patients.  Ann Thorac Surg. 2000;  70 813-818 819
• 13 Penta de Peppo A, Nardi P, De Paulis R. et al . Cardiac surgery in moderate to end-stage renal failure: analysis of risk factors.  Ann Thorac Surg. 2002;  74 378-383
• 14 Hosoda Y, Yamamoto T, Takazawa K. et al . Coronary artery bypass grafting in patients on chronic hemodialysis: surgical outcome in diabetic nephropathy versus nondiabetic nephropathy patients.  Ann Thorac Surg. 2001;  71 543-548
• 15 Khaitan L, Sutter F P, Goldman S M. Coronary artery bypass grafting in patients who require long-term dialysis.  Ann Thorac Surg. 2000;  69 1135-1139
• 16 Herzog C A, Ma J Z, Collins A J. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified?.  Circulation. 2002;  105 1336-1341
• 17 Nakayama Y, Sakata R, Ura M. Early results and characteristic problems associated with cardiac surgery in long-term dialysis patients.  Jpn J Thorac Cardiovasc Surg. 2001;  49 420-423
• 18 Liu J Y, Birkmeyer N J, Sanders J H. et al . Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group.  Circulation. 2000;  102 2973-2977
• 19 Luke R G. Chronic renal failure - a vasculopathic state.  N Engl J Med. 1998;  339 841-843
• 20 Szczech L A, Best P J, Crowley E. et al . Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.  Circulation. 2002;  105 2253-2258
• 21 Herzog C A, Ma J Z, Collins A J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.  N Engl J Med. 1998;  339 799-805
• 22 Gradaus F, Schoebel F C, Ivens K. et al . [Rate of restenosis after PTCA in patients with terminal renal failure. A quantitative coronary angiography study].  Z Kardiol. 1997;  86 373-379
• 23 Schoebel F C, Gradaus F, Ivens K. et al . Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography.  Heart. 1997;  78 337-342
• 24 Rubenstein M H, Harrell L C, Sheynberg B V. et al . Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?.  Circulation. 2000;  102 2966-2972
• 25 Reddan D N, Szczech L A, Tuttle R H. et al . Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.  J Am Soc Nephrol. 2003;  14 2373-2380
• 26 Rihal C S, Textor S C, Grill D E. et al . Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.  Circulation. 2002;  105 2259-2264
• 27 Ferguson Jr T B, Hammill B G, Peterson E D, DeLong E R, Grover F L. A decade of change - risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990 - 1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons.  Ann Thorac Surg. 2002;  73 480-489 489-490
• 28 Feinberg W M, Blackshear J L, Laupacis A, Kronmal R, Hart R G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.  Arch Intern Med. 1995;  155 469-473
• 29 Wolf P A, Abbott R D, Kannel W B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.  Stroke,. 1991;  22 983-988
• 30 Waldo A L. A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need.  Am Heart J. 2006;  151 771-778
• 31 Zebe H. Atrial fibrillation in dialysis patients.  Nephrol Dial Transplant. 2000;  15 765-768
• 32 Fabbian F, Catalano C, Lambertini D. et al . Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients.  Clin Nephrol. 2000;  54 234-239
• 33 Vazquez E, Sanchez-Perales C, Borrego F. et al . Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis.  Am Heart J. 2000;  140 886-890
• 34 Stewart S, Hart C L, Hole D J, McMurray J J. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.  Am J Med. 2002;  113 359-364